TIM3 blockade with hypomethylating therapy restores NK and cytotoxic CD4+ T cell activity in patients with AML or MDS
Jani Huuhtanen(University of Helsinki), Satu Mustjoki(University of Helsinki)
Cited by 0
Related Papers
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis
|Nature Communications|2017|123
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
|Blood|2022|123
Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma
|Journal of Clinical Investigation|2023|93
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation
|Blood Cancer Journal|2013|63